Advancement in Insulcagon pump simulating as an artificial pancreas for the treatment of diabetes

Diabetes Mellitus prevalence is escalating in epidemic proportions on the global basis. This disease affects various body organs. Due to that reason, it should be treated effectively. Hyperglycemia, a condition of diabetes is treated via insulin pump, pens and injections while hypoglycemia is treated by only glucagon injections. Significantly, there are not any such pumps available in the market aimed for the treatment of both condition simultaneously. Whereas our designed prototype pump named as insulcagon pump have ability to control both situations. This prototype has invitro continuous glucose sensor that senses blood glucose level whose output goes to micro controller that decides which pump to be activated either insulin or glucagon pump in order to maintain blood glucose level. That´s why Insulcagon pump acts as an artificial pancreas for diabetic patients. The adequate results of this prototype shown in graphical form in this paper. We added advance features in Insulcagon pump that will considered as an era towards device modernization. Thus we incremented some peculiar functions in this medical instrument. These functions include: trends, modes and power compatibility. Trend provides the past record of activities according to the time selected. Modes have options for the user to select calibration, auto-mode and manual selection mode. These modes assist in providing required amount of bolus directly injected into the body. Power compatibility option prevents disruption in the continuity of the device. We expect that our designed prototype will be beneficial for the effective treatment of Diabetic patients and biomedical companies will play important role in the enhancement and the accuracy of device according to the guidelines of American diabetic association.